Psychemedics Revenue 2010-2024 | PMD

Psychemedics revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Psychemedics Annual Revenue
(Millions of US $)
2023 $22
2022 $25
2021 $25
2020 $21
2019 $38
2018 $43
2017 $40
2016 $39
2015 $27
2014 $29
2013 $27
2012 $25
2011 $24
2010 $20
2009 $17
Psychemedics Quarterly Revenue
(Millions of US $)
2024-03-31 $5
2023-12-31 $5
2023-09-30 $6
2023-06-30 $6
2023-03-31 $6
2022-12-31 $6
2022-09-30 $7
2022-06-30 $7
2022-03-31 $7
2021-12-31 $6
2021-09-30 $7
2021-06-30 $6
2021-03-31 $6
2020-12-31 $5
2020-09-30 $5
2020-06-30 $3
2020-03-31 $8
2019-12-31 $9
2019-09-30 $10
2019-06-30 $9
2019-03-31 $10
2018-12-31 $10
2018-09-30 $11
2018-06-30 $11
2018-03-31 $11
2017-12-31 $10
2017-09-30 $10
2017-06-30 $10
2017-03-31 $10
2016-12-31 $11
2016-09-30 $12
2016-06-30 $10
2016-03-31 $7
2015-12-31 $6
2015-09-30 $7
2015-06-30 $7
2015-03-31 $7
2014-12-31 $7
2014-09-30 $8
2014-06-30 $8
2014-03-31 $7
2013-12-31 $6
2013-09-30 $7
2013-06-30 $7
2013-03-31 $6
2012-12-31 $6
2012-09-30 $6
2012-06-30 $7
2012-03-31 $6
2011-12-31 $6
2011-09-30 $6
2011-06-30 $6
2011-03-31 $6
2010-12-31 $5
2010-09-30 $5
2010-06-30 $5
2010-03-31 $4
2009-12-31 $4
2009-09-30 $5
2009-06-30 $4
2009-03-31 $4
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.013B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
Quest Diagnostics (DGX) United States $15.637B 16.16
DaVita (DVA) United States $12.266B 15.23
Elanco Animal Health (ELAN) United States $9.068B 23.53
Encompass Health (EHC) United States $8.515B 21.80
Chemed (CHE) United States $8.153B 25.27
Option Care Health (OPCH) United States $4.910B 18.59
RadNet (RDNT) United States $4.516B 94.05
Amedisys (AMED) United States $3.000B 21.25
Astrana Health (ASTH) United States $2.226B 30.11
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.932B 27.64
U.S Physical Therapy (USPH) United States $1.433B 38.36
Pennant (PNTG) United States $0.697B 36.81
Aveanna Healthcare Holdings (AVAH) United States $0.483B 0.00
Atai Life Sciences (ATAI) Germany $0.221B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.025B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Novo Integrated Sciences (NVOS) United States $0.018B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00